Citigroup Inc Novo Nordisk A S Call Options Transaction History

Citigroup Inc

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 12, 2024	BUY	$119.07 - $145.42 $11.7 Million - $14.3 Million	98,000 New	98,000 $11.7 Million
Q1 2024 May 10, 2024	BUY	$102.11 - $135.92 $1.44 Million - $1.92 Million	14,100 Added 188.0%	21,600 $2.77 Million
Q4 2023 Feb 09, 2024	SELL	$87.78 - $105.45 $2.95 Million - $3.54 Million	-33,600 Reduced 81.75%	7,500 $775,000
Q3 2023 Nov 09, 2023	BUY	$90.94 - $199.54 $3.74 Million - $8.2 Million	41,100 New	41,100 $3.74 Million
Q2 2022 Aug 10, 2022	BUY	$103.24 - $121.81 $5.34 Million - $6.3 Million	51,700 New	51,700 $5.76 Million

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $200B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.